Terminated × Carcinoma, Non-Small-Cell Lung × Cisplatin × Clear all A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
AcceleRET-Lung
Phase 3 Terminated
223 enrolled 18 charts
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 16 charts
BRIDGE
Phase 2 Terminated
10 enrolled
CONTERNO
Phase 3 Terminated
25 enrolled 10 charts
Induction
Phase 1 Terminated
18 enrolled
Phalcis
Phase 2 Terminated
57 enrolled 18 charts
To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer
Phase 3 Terminated
132 enrolled
BREC
Phase 3 Terminated
382 enrolled 15 charts
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
153 enrolled 13 charts
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Phase 1/2 Terminated
67 enrolled 24 charts
PROPEL
Phase 1/2 Terminated
162 enrolled 21 charts
Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC
Phase 1 Terminated
9 enrolled
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
Phase 1 Terminated
111 enrolled
Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
Phase 3 Terminated
20 enrolled 14 charts
A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma
Phase 1/2 Terminated
60 enrolled 24 charts
Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC
Phase 2 Terminated
4 enrolled
Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Terminated
59 enrolled 16 charts
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Phase 3 Terminated
2 enrolled 6 charts
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
Phase 3 Terminated
8 enrolled 9 charts
METAL2
Phase 3 Terminated
95 enrolled
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
Phase 2 Terminated
7 enrolled 9 charts
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer
Phase 1 Terminated
8 enrolled
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Phase 2 Terminated
76 enrolled 13 charts
NeoIntercal
Phase 2/3 Terminated
1 enrolled
HighTySy
Phase 2 Terminated
2 enrolled
Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer
Phase 1 Terminated
71 enrolled
LCCC1407
Phase 2 Terminated
1 enrolled 5 charts
CAPPA-2
Phase 3 Terminated
57 enrolled
TIME
Phase 2/3 Terminated
222 enrolled
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
Phase 1 Terminated
15 enrolled 10 charts
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
Phase 1/2 Terminated
8 enrolled 4 charts
Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer
Phase 1 Terminated
4 enrolled
Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
Phase 2 Terminated
3 enrolled 3 charts
TRAIL
Phase 3 Terminated
148 enrolled
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Phase 1/2 Terminated
1 enrolled 4 charts
HALO
Phase 1 Terminated
82 enrolled
Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer
Phase 3 Terminated
125 enrolled
Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571
Phase 1/2 Terminated
43 enrolled 10 charts
TOP0602
Phase 2 Terminated
101 enrolled 12 charts
TOP0703
Phase 2 Terminated
31 enrolled 10 charts
Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer
Phase 2 Terminated
13 enrolled 4 charts
A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin
Phase 1 Terminated
8 enrolled
Customizing
Phase 2 Terminated
3 enrolled
SMART
Phase 2 Terminated
11 enrolled 5 charts
Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Phase 1 Terminated
44 enrolled
Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
Phase 3 Terminated
19 enrolled 5 charts
S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
33 enrolled
Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer
Phase 1 Terminated
48 enrolled
CisPemXetSrg
Phase 1 Terminated
48 enrolled